Abstract
In nearly all human cells IFN-γ Stimulation leads to an activation of indoleamine 2,3-dioxygenase (IDO) activity, which is responsible for anti-toxoplasma and anti-chlamydia effects. We have recently shown that IDO activation is also a defense mechanism against extracellular β-hemolytic streptococci groups A,B,C and G in human glioblastoma cells, fibroblasts and macrophages. Similar effects were also seen with enterococci and in approximately 65% of staphylococci tested, including multiresistant strains of both species. In addition, we have found that IDO activity is differentially regulated in different cells. For example we have found that TNF-α enhances IFN-γ induced IDO activity and antimicrobial effect in human glioblastoma cells whereas both IFN-γ mediated effects were blocked by TNF-α as well as by IL-1 in a human uroepithelial cell line. We were able to show that the IL-1 and TNF-α mediated inhibition of IFN-γ-induced IDO activity in uroepithelial cells is due to stimulation of inducible nitric oxide synthase. In human astrocytoma cells, IL-1 and TNF-α did not inhibit IDO activity and in concordance with this finding these cells did not show a detectable nitric oxide production.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Byrne, J.I., Lehmann, L.K., and Landry, G.J., 1986, Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells, Infect. Immun. 53:347–351.
Däubener, W. and Hadding, U., 1997, Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system, Med. Microbiol. Immunol. 185:195–206.
Däubener, W., Nockemann, S., Gutsche, M., and Hadding, U., 1995, Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γ, Eur. J. Immunol. 25:688–692.
Däubener, W., Pilz, K., Seghrouchni-Zennati, S., Bilzer, T., Fischer, H.G., and Hadding, U., 1993, Induction of toxoplasmostasis in a human glioblastoma by interferon-γ, J. Neuroimmunol. 43:31–38.
Farrar, M.A. and Schreiber, R.D., 1993, The molecular cell biology of interferon-γ and its receptor, Annu. Rev. Immunol. 11:571–611.
Habara-Ohkubo, A., Shirahata, T., Takikawa, O., and Yoshida, R., 1993, Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase, Infect. Immun. 61:1810–1813.
Hayaishi, O., Hirata, F., Ohnishi, T., Henry, J.P., Rosenthal, I., and Katoh, A., 1988, Indoleamine 2,3-dioxygenase, J. Biol. Chem. 252:3548–3550.
Heyes, M.P., Achim, C.L., Wiley, C.A., Major, E.O., Saito, K., and Markey, S.P., 1996, Human microglia convert L-tryptophan into the neurotoxin quinolinic acid, J. Biochem. 320:595–597.
Lee, S.C., Dickson, D.W., Brosnan, C.F., and Cassadevall, 1994, Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism, J. Exp. Med. 180:365–369.
Liew, F.Y. and Cox, F.E.G., 1991, Nonspecific defence mechanism: the role of nitric oxide, Immunol. Today 12:A17–21.
Liew, F.Y., Li, Y., Moss, D., Rogers, M.V., and Moncada, S., 1991, Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages, Eur. J. Immunol. 21:3009–3014.
MacKenzie, C.R., Hadding, U., and Däubener, W., 1998, Interferon-γ induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte derived macrophages inhibits the growth of group B streptococci, J. Infect. Dis. 178:875–878.
MacKenzie, C.R., Willberg, C.B., and Däubener, W., 1998, Inhibition of group B streptococcal growth by IFN-γ activated human glioblastoma cells, J. Neuroimmunol. 89:191–197.
Meda, L., Cassatella, M.A., Szendrei G.I., Otvos, L., Baron, P., Villalba, M., Ferrari, D, and Rossi, F., 1995, Activation of microglial cells by b-amyloid protein and interferon-γ, Nature. 374:647–650.
Mellio, G., Cox, G.W., Radzioch, D., and Varesio, L., 1993, Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages, J. Immunol. 150:4031–4040.
Murray, H.W., Szuro-Sudol, A., Wellner, D., Oca, M.J., Granger, A.M., Libby, D.M., Rothermel, C.D., and Rubin, B.Y., 1989, Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages, Infect. Immun. 57:845–849.
Murray H.W. and Teitelbaum, R.F., 1992, L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes, J. Infect. Dis. 165:513–517.
Nagineni, C.N., Pardhasaradhi, K., Martins, M.C., Detrick, B., and Hooks, J.J., 1996, Mechanisms of inter-feron-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells, Infect. Immun. 64:4188–4196.
Ozaki, Y., Edelstein, M.P., and Duch, D.S., 1988, Induction of indolamine 2,3-dioxygenase: A mechanism of the antitumor activity of interferon-γ, Proc. Natl. Acad. Sci. USA. 85:1242–1246.
Peterson, P.K., Gekker, G., Hu, S., and Chao, C.C., 1995, Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism, J. Infect. Dis. 171:516–518.
Pfefferkorn, E.R., 1984, Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degradate tryptophan. Proc. Natl. Acad. Sci. USA. 81:908–912.
Roilides, E., Uhlig, K., Venzon, D., Pizzo, P.A., and Walsh, T.J., 1993, Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony stimulating factor and gamma interferon, Infect. Immun. 61:1185–1193.
Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerro, L., and Schaffner, A., 1993, Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes, J. Infect. Dis. 167:1358–1363.
Shimizu, T., Nomiyama, S., Hirata, F., and Hayaishi, O., 1978, Indoleamine 2,3-dioxygenase, J. Biol. Chem. 253:4700–4706.
Sibley, D., Messina, M., and Niesman, I.R., 1994, Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy, Proc. Natl. Acad. Sci. USA. 91:5508–5512.
Stone, T.W., 1993, Neuropharmacology of quinolonic and kynurenic acids, Pharmacol. Rev. 45:309–379.
Taylor, M.W. and Feng, G., 1991, Relationship between interferon-γ, indoleamine 2,3-dioxygenase, and tryptophan catabolism, J. FASEB. 5:2516–2522. AR308.
Thomas, S.M., Garrity, L.F., Brandt, C.R., Schobert, C.S., Feng, G.S., Taylor, M.W, Carlin, J.M., and Byrne, G.I., 1993, IFN-γ mediated antimicrobial response, J. Immunol. 150:5529–5534.
Thomas, S.R., Mohr, D., and Stocker, R., 1994, Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-γ primed mononuclear phagocytes, J. Biol. Chem. 269:14457–14464.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Däubener, W., MacKenzie, C.R. (1999). Ifn-γ Activated Indoleamine 2,3-Dioxygenase Activity in Human Cells is an Antiparasitic and an Antibacterial Effector Mechanism. In: Huether, G., Kochen, W., Simat, T.J., Steinhart, H. (eds) Tryptophan, Serotonin, and Melatonin. Advances in Experimental Medicine and Biology, vol 467. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4709-9_64
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4709-9_64
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7133-5
Online ISBN: 978-1-4615-4709-9
eBook Packages: Springer Book Archive